Park J W, Blanchette-Mackie E J, Scow R O
Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Biochem J. 1996 Jul 1;317 ( Pt 1)(Pt 1):125-34. doi: 10.1042/bj3170125.
Brown adipocytes cultured from newborn combined-lipase-deficient (cld/cld) mice and castanospermine (CST)-treated 3T3-L1 adipocytes synthesize lipoprotein lipase (LPL) which is inactive and retained in the endoplasmic reticulum (ER) [Masuno, Blanchette-Mackie, Chernick and Scow (1990) J.Biol. Chem. 265, 1628-1638; Masuno, Blanchette-Mackie, Schultz, Spaeth, Scow and Okuda (1992) J. Lipid Res.33, 1343-1349]. Brefeldin A (BFA), which is known to block protein transport from ER and translocate Golgi components to ER, was used here to study the effect of translocated Golgi enzymes on LPL retained in ER of cld/cld and CST-treated mouse brown adipocytes. Brown adipocytes cultured from newborn normal mice contained 3000-5000 m-units of LPL activity/mg of DNA and secreted 35 m-units of LPL activity/mg of DNA per h. BFA at 10 micrograms/ml doubled LPL activity in normal cells within 2 h as it stopped completely secretion of active LPL. LPL in mouse cells has two N-oligosaccharide chains per subunit. Analyses with SDS/PAGE and immunoblotting showed that about one-third of LPL subunits in untreated normal cells were totally endo-beta-N-acetylglucosaminidase (endo H)-resistant, one-third were partially endo H-resistant, and one-third were totally endo H-sensitive. BFA decreased to zero the proportion of subunits which were totally endo H-resistant, while it increased the proportion which were partially endo H-resistant. Thus, BFA blocked processing of one oligosaccharide chain per subunit to endo H-resistance. Sucrose-gradient centrifugation studies showed that BFA increased the proportion of LPL subunits in normal cells which were present as active dimers. LPL activity in cld/cld adipocytes was 120 m-units/mg of DNA and that in normal adipocytes treated with CST was 430 m-units/mg of DNA. Most LPL subunits in such cells were totally endo H-sensitive and some were partially endo H-resistant, but none were totally endo H-resistant. Some of the subunits, in both cld/cld and CST-treated cells, were present as inactive LPL dimers. BFA increased LPL activity in cld/cld cells to 2100 m-units/mg of DNA and that in CST-treated cells to 2600 m-units/mg of DNA within 2 h. BFA increased in both groups the proportion of LPL subunits which were partially endo H-resistant. BFA also increased the proportion which were present as active dimers. Immunofluorescence studies in normal and cld/cld adipocytes showed that BFA caused retention of LPL in large tubular and spherical structures and in ER, but not in Golgi. When BFA was withdrawn and protein synthesis was blocked with cycloheximide, LPL in normal cells was transferred to Golgi within 30 min and disappeared within 60 min, whereas LPL in cld/cld cells was retained in large vesicles and ER. The findings indicate that BFA enabled synthesis of active LPL in cld/cld and CST-treated cells via translocation of Golgi components to ER. Also, cld/cld cells synthesized LPL which could be processed to active lipase and the enzymes needed for activation of the lipase were present in Golgi of such cells. Production of inactive LPL in cld/cld adipocytes probably results from their inability to transport LPL from ER to Golgi.
从新生的联合脂肪酶缺陷(cld/cld)小鼠培养的棕色脂肪细胞以及经栗精胺(CST)处理的3T3-L1脂肪细胞合成的脂蛋白脂肪酶(LPL)是无活性的,并保留在内质网(ER)中[增野、布兰切特-麦基、切尔尼克和斯科(1990年)《生物化学杂志》265卷,第1628 - 1638页;增野、布兰切特-麦基、舒尔茨、斯佩斯、斯科和奥库达(1992年)《脂质研究杂志》33卷,第1343 - 1349页]。布雷菲德菌素A(BFA)已知可阻断蛋白质从内质网的转运并使高尔基体成分转位至内质网,在此用于研究转位的高尔基体酶对cld/cld和经CST处理的小鼠棕色脂肪细胞内质网中保留的LPL的影响。从新生正常小鼠培养的棕色脂肪细胞每毫克DNA含有3000 - 5000 m单位的LPL活性,每小时分泌35 m单位的LPL活性/毫克DNA。10微克/毫升的BFA在2小时内使正常细胞中的LPL活性增加一倍,因为它完全停止了活性LPL的分泌。小鼠细胞中的LPL每个亚基有两条N - 寡糖链。SDS/PAGE和免疫印迹分析表明,未处理的正常细胞中约三分之一的LPL亚基对内切β - N - 乙酰葡糖胺糖苷酶(内切H)完全耐药,三分之一部分耐药,三分之一对内切H敏感。BFA使对内切H完全耐药的亚基比例降至零,同时增加了部分耐药的亚基比例。因此,BFA阻断了每个亚基一条寡糖链向对内切H耐药的加工过程。蔗糖梯度离心研究表明,BFA增加了正常细胞中以活性二聚体形式存在的LPL亚基的比例。cld/cld脂肪细胞中的LPL活性为120 m单位/毫克DNA,经CST处理的正常脂肪细胞中的LPL活性为430 m单位/毫克DNA。此类细胞中的大多数LPL亚基对内切H完全敏感,有些部分耐药,但没有完全耐药的。在cld/cld和经CST处理的细胞中,一些亚基以无活性的LPL二聚体形式存在。BFA在2小时内使cld/cld细胞中的LPL活性增加到2100 m单位/毫克DNA,使经CST处理的细胞中的LPL活性增加到2600 m单位/毫克DNA。BFA在两组中都增加了部分对内切H耐药的LPL亚基的比例。BFA还增加了以活性二聚体形式存在的比例。对正常和cld/cld脂肪细胞的免疫荧光研究表明,BFA导致LPL保留在大的管状和球形结构以及内质网中,而不是高尔基体中。当撤去BFA并用环己酰亚胺阻断蛋白质合成时,正常细胞中的LPL在30分钟内转移至高尔基体并在60分钟内消失,而cld/cld细胞中的LPL保留在大囊泡和内质网中。这些发现表明,BFA通过高尔基体成分转位至内质网使cld/cld和经CST处理的细胞中合成活性LPL。此外,cld/cld细胞合成的LPL可被加工成活性脂肪酶,并且此类细胞的高尔基体中存在激活脂肪酶所需的酶。cld/cld脂肪细胞中无活性LPL的产生可能是由于它们无法将LPL从内质网转运至高尔基体。